Blood clot risk in hospitalized acute leukemia patients
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how often hospitalized patients with acute leukemia develop blood clots. By tracking this, doctors hope to learn who might be at higher risk and find better ways to prevent clots in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a new diagnosis of acute leukemia (a type of blood cancer). This includes APL, AML, or ALL.
- You must be staying in a hospital hematology ward (a unit for blood conditions) for at least 2 days.
- You should not be taking blood-thinning medicine at a full treatment dose when you enter the study.
- You should not have had a blood clot or major bleeding within the first 48 hours of being in the hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a new scoring system predicts bleeding and clotting risks in people newly diagnosed with acute leukemia. By participating, you may help improve how doctors assess and manage these risks.
This study is looking at blood and bone marrow samples from people with acute leukemia to understand how the immune system reacts to the disease and treatment. The goal is to find better ways to treat leukemia.
This study looks at how blood and clotting are affected in people newly diagnosed with acute myeloid leukemia (AML) who receive a common intensive chemotherapy combination (idarubicin and cytarabine). The goal is to better understand blood-related side effects and improve care.
This trial studies whether the levels of certain proteins and blood clotting factors in your blood can help doctors understand acute myeloid leukemia better. It may lead to better ways to monitor the disease and its effects on your body.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study looks at how bleeding problems in patients with cancer affect the body's ability to break down blood clots. Researchers hope to find better ways to manage and treat these complications.
Hear when a new Acute Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.